SGLT2 inhibitors in cardiovascular medicine

Eur Heart J Cardiovasc Pharmacother. 2021 Jul 23;7(4):e67-e68. doi: 10.1093/ehjcvp/pvab039.

Authors

Fahimeh Varzideh^{1

2}, Urna Kansakar^{1

2}, Gaetano Santulli^{1

2}

Affiliations

¹ Department of Medicine, Einstein-Mount Sinai Diabetes Research Center (ES-DRC), Fleischer Institute for Diabetes and Metabolism (FIDAM), Albert Einstein College of Medicine, 1300 Morris Park Avenue, New York, NY 10461, USA.
² Department of Molecular Pharmacology, Wilf Family Cardiovascular Research Institute, Einstein Institute for Aging Research, Albert Einstein College of Medicine, 1300 Morris Park Avenue, New York, NY 10461, USA.

No abstract available

MeSH terms

Blood Glucose
Diabetes Mellitus, Type 2*
Humans
Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use

Substances

Blood Glucose
Sodium-Glucose Transporter 2 Inhibitors

Grants and funding